Supplementary material for A study of ultra-low dose rituximab as adjuvant to standard of care in treatment of significant and extensive pemphigus vulgaris: a case series
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/5tkdw2p4y7
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary material contains two figures. Figure 1 shows recruitment data for the study and figure 2 depicts graph showing absolute CD19 cell count before and after rituximab therapy. Text after the figures explains PDAI-classification of pemphigus vulgaris disease severity.
提供机构：
Gujarat Cancer Society Medical College
